Stocks · News reference
8-K filing — Annexon, Inc. (ANNX)
Filed: 2026-08-12 AccNo: 0001193125-26-345672 Size: 260 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Annexon Announces Presentations On Vonaprument For Geographic Atrophy At Retina Society Meeting; Says Phase 3 Results Expected In Q4 2026
JP Morgan Maintains Overweight on Annexon, Raises Price Target to $14
Citizens Upgrades Annexon to Market Perform
Citizens analyst Jonathan Wolleben upgrades Annexon (NASDAQ:ANNX) from Market Underperform to Market Perform.